vs

Side-by-side financial comparison of Charles River Laboratories (CRL) and Sally Beauty Holdings, Inc. (SBH). Click either name above to swap in a different company.

Charles River Laboratories is the larger business by last-quarter revenue ($995.8M vs $943.2M, roughly 1.1× Sally Beauty Holdings, Inc.). Sally Beauty Holdings, Inc. runs the higher net margin — 4.8% vs -1.5%, a 6.3% gap on every dollar of revenue. On growth, Charles River Laboratories posted the faster year-over-year revenue change (1.2% vs 0.6%). Over the past eight quarters, Sally Beauty Holdings, Inc.'s revenue compounded faster (1.9% CAGR vs -1.5%).

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices.

Sally Beauty Holdings, Inc. is an American international specialty retailer and distributor of professional beauty supplies with revenues of more than $3.9 billion annually.

CRL vs SBH — Head-to-Head

Bigger by revenue
CRL
CRL
1.1× larger
CRL
$995.8M
$943.2M
SBH
Growing faster (revenue YoY)
CRL
CRL
+0.6% gap
CRL
1.2%
0.6%
SBH
Higher net margin
SBH
SBH
6.3% more per $
SBH
4.8%
-1.5%
CRL
Faster 2-yr revenue CAGR
SBH
SBH
Annualised
SBH
1.9%
-1.5%
CRL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CRL
CRL
SBH
SBH
Revenue
$995.8M
$943.2M
Net Profit
$-14.8M
$45.6M
Gross Margin
51.2%
Operating Margin
12.0%
8.1%
Net Margin
-1.5%
4.8%
Revenue YoY
1.2%
0.6%
Net Profit YoY
-157.2%
-25.3%
EPS (diluted)
$-0.30
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRL
CRL
SBH
SBH
Q1 26
$995.8M
Q4 25
$994.2M
$943.2M
Q3 25
$1.0B
$947.1M
Q2 25
$1.0B
$933.3M
Q1 25
$984.2M
$883.1M
Q4 24
$1.0B
$937.9M
Q3 24
$1.0B
$935.0M
Q2 24
$1.0B
$942.3M
Net Profit
CRL
CRL
SBH
SBH
Q1 26
$-14.8M
Q4 25
$-276.6M
$45.6M
Q3 25
$54.4M
$49.9M
Q2 25
$52.3M
$45.7M
Q1 25
$25.5M
$39.2M
Q4 24
$-214.5M
$61.0M
Q3 24
$69.7M
$48.1M
Q2 24
$94.1M
$37.7M
Gross Margin
CRL
CRL
SBH
SBH
Q1 26
Q4 25
51.2%
Q3 25
52.2%
Q2 25
51.5%
Q1 25
52.0%
Q4 24
50.8%
Q3 24
34.6%
51.2%
Q2 24
34.5%
51.0%
Operating Margin
CRL
CRL
SBH
SBH
Q1 26
12.0%
Q4 25
-28.5%
8.1%
Q3 25
13.3%
8.4%
Q2 25
9.7%
8.4%
Q1 25
7.6%
7.9%
Q4 24
-16.7%
10.7%
Q3 24
11.6%
8.8%
Q2 24
14.8%
7.6%
Net Margin
CRL
CRL
SBH
SBH
Q1 26
-1.5%
Q4 25
-27.8%
4.8%
Q3 25
5.4%
5.3%
Q2 25
5.1%
4.9%
Q1 25
2.6%
4.4%
Q4 24
-21.4%
6.5%
Q3 24
6.9%
5.1%
Q2 24
9.2%
4.0%
EPS (diluted)
CRL
CRL
SBH
SBH
Q1 26
$-0.30
Q4 25
$-5.57
$0.45
Q3 25
$1.10
$0.49
Q2 25
$1.06
$0.44
Q1 25
$0.50
$0.38
Q4 24
$-4.17
$0.58
Q3 24
$1.33
$0.45
Q2 24
$1.74
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRL
CRL
SBH
SBH
Cash + ST InvestmentsLiquidity on hand
$191.8M
$157.2M
Total DebtLower is stronger
$842.5M
Stockholders' EquityBook value
$2.9B
$823.6M
Total Assets
$7.7B
$2.9B
Debt / EquityLower = less leverage
1.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRL
CRL
SBH
SBH
Q1 26
$191.8M
Q4 25
$213.8M
$157.2M
Q3 25
$207.1M
$149.2M
Q2 25
$182.8M
$112.8M
Q1 25
$229.4M
$92.2M
Q4 24
$194.6M
$105.5M
Q3 24
$210.2M
$108.0M
Q2 24
$179.2M
$97.4M
Total Debt
CRL
CRL
SBH
SBH
Q1 26
Q4 25
$2.1B
$842.5M
Q3 25
$2.2B
$862.0M
Q2 25
$2.3B
$882.4M
Q1 25
$2.5B
$902.8M
Q4 24
$2.2B
$938.1M
Q3 24
$2.3B
$978.3M
Q2 24
$2.4B
$978.9M
Stockholders' Equity
CRL
CRL
SBH
SBH
Q1 26
$2.9B
Q4 25
$3.2B
$823.6M
Q3 25
$3.4B
$794.2M
Q2 25
$3.4B
$762.9M
Q1 25
$3.2B
$699.8M
Q4 24
$3.5B
$656.5M
Q3 24
$3.8B
$628.5M
Q2 24
$3.7B
$577.7M
Total Assets
CRL
CRL
SBH
SBH
Q1 26
$7.7B
Q4 25
$7.1B
$2.9B
Q3 25
$7.5B
$2.9B
Q2 25
$7.6B
$2.7B
Q1 25
$7.6B
$2.7B
Q4 24
$7.5B
$2.7B
Q3 24
$8.0B
$2.8B
Q2 24
$7.9B
$2.7B
Debt / Equity
CRL
CRL
SBH
SBH
Q1 26
Q4 25
0.68×
1.02×
Q3 25
0.64×
1.09×
Q2 25
0.70×
1.16×
Q1 25
0.79×
1.29×
Q4 24
0.65×
1.43×
Q3 24
0.62×
1.56×
Q2 24
0.65×
1.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRL
CRL
SBH
SBH
Operating Cash FlowLast quarter
$41.1M
$93.2M
Free Cash FlowOCF − Capex
$57.5M
FCF MarginFCF / Revenue
6.1%
Capex IntensityCapex / Revenue
5.6%
3.8%
Cash ConversionOCF / Net Profit
2.05×
TTM Free Cash FlowTrailing 4 quarters
$216.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRL
CRL
SBH
SBH
Q1 26
$41.1M
Q4 25
$147.5M
$93.2M
Q3 25
$213.8M
$120.9M
Q2 25
$204.6M
$69.4M
Q1 25
$171.7M
$51.1M
Q4 24
$159.4M
$33.5M
Q3 24
$251.8M
$110.7M
Q2 24
$193.5M
$47.9M
Free Cash Flow
CRL
CRL
SBH
SBH
Q1 26
Q4 25
$58.6M
$57.5M
Q3 25
$178.2M
$78.0M
Q2 25
$169.3M
$49.1M
Q1 25
$112.4M
$32.2M
Q4 24
$83.7M
$13.4M
Q3 24
$213.1M
$73.3M
Q2 24
$154.0M
$28.7M
FCF Margin
CRL
CRL
SBH
SBH
Q1 26
Q4 25
5.9%
6.1%
Q3 25
17.7%
8.2%
Q2 25
16.4%
5.3%
Q1 25
11.4%
3.6%
Q4 24
8.4%
1.4%
Q3 24
21.1%
7.8%
Q2 24
15.0%
3.1%
Capex Intensity
CRL
CRL
SBH
SBH
Q1 26
5.6%
Q4 25
8.9%
3.8%
Q3 25
3.5%
4.5%
Q2 25
3.4%
2.2%
Q1 25
6.0%
2.1%
Q4 24
7.5%
2.1%
Q3 24
3.8%
4.0%
Q2 24
3.8%
2.0%
Cash Conversion
CRL
CRL
SBH
SBH
Q1 26
Q4 25
2.05×
Q3 25
3.93×
2.42×
Q2 25
3.91×
1.52×
Q1 25
6.74×
1.30×
Q4 24
0.55×
Q3 24
3.61×
2.30×
Q2 24
2.06×
1.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRL
CRL

Service revenue$798.2M80%
Product revenue$197.7M20%

SBH
SBH

Sally Beauty Supply$531.6M56%
Beauty Systems Group$411.6M44%

Related Comparisons